BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Hemelrijck M, Jassem W, Walldius G, Fentiman IS, Hammar N, Lambe M, Garmo H, Jungner I, Holmberg L. Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study. Eur J Cancer. 2011;47:2033-2041. [PMID: 21486691 DOI: 10.1016/j.ejca.2011.03.010] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Fentiman IS. Gamma-glutamyl transferase: risk and prognosis of cancer. Br J Cancer 2012;106:1467-8. [PMID: 22531718 DOI: 10.1038/bjc.2012.128] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
2 He MM, Fang Z, Hang D, Wang F, Polychronidis G, Wang L, Lo CH, Wang K, Zhong R, Knudsen MD, Smith SG, Xu RH, Song M. Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank. Int J Cancer 2021;148:1867-78. [PMID: 33091956 DOI: 10.1002/ijc.33351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Mok Y, Son DK, Yun YD, Jee SH, Samet JM. γ-Glutamyltransferase and cancer risk: The Korean cancer prevention study. Int J Cancer 2016;138:311-9. [PMID: 26111622 DOI: 10.1002/ijc.29659] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
4 Hernaez R, Yeh H, Lazo M, Chung H, Hamilton JP, Koteish A, Potter JJ, Brancati FL, Clark JM. Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study. Hepatol Int 2013;7:1040-9. [DOI: 10.1007/s12072-013-9476-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
5 Wang Y, Wang M, Li H, Chen K, Zeng H, Bi X, Zhu Z, Jiao Y, Wang Y, Zhu J, Zhao H, Liu X, Dai C, Fan C, Zhao C, Guo D, Zhao H, Zhou J, Wang D, Wu Z, Zhao X, Cui W, Zhang X, Cai J, Chen W, Qu C. A male-ABCD algorithm for hepatocellular carcinoma risk prediction in HBsAg carriers. Chin J Cancer Res 2021;33:352-63. [PMID: 34321832 DOI: 10.21147/j.issn.1000-9604.2021.03.07] [Reference Citation Analysis]
6 Yiu A, Van Hemelrijck M, Garmo H, Holmberg L, Malmström H, Lambe M, Hammar N, Walldius G, Jungner I, Wulaningsih W. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study. Oncotarget 2017;8:42332-42. [PMID: 28418841 DOI: 10.18632/oncotarget.16198] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
7 Xiao Y, Yang H, Lu J, Li D, Xu C, Risch HA. Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer.BMC Cancer. 2019;19:1020. [PMID: 31664937 DOI: 10.1186/s12885-019-6250-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
8 Fu SJ, Zhao Q, Ji F, Chen MG, Wu LW, Ren QQ, Guo ZY, He XS. Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation. Sci Rep. 2016;6:28835. [PMID: 27381639 DOI: 10.1038/srep28835] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
9 Seol A, Wang W, Kim SI, Han Y, Park IS, Yoo J, Jo H, Han KD, Song YS. Enhanced Susceptibility to Breast Cancer in Korean Women With Elevated Serum Gamma-Glutamyltransferase Levels: A Nationwide Population-Based Cohort Study. Front Oncol 2021;11:668624. [PMID: 34123839 DOI: 10.3389/fonc.2021.668624] [Reference Citation Analysis]
10 Hann HW, Wan S, Myers RE, Hann RS, Xing J, Chen B, Yang H. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PLoS One. 2012;7:e47687. [PMID: 23112834 DOI: 10.1371/journal.pone.0047687] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
11 Gallegos-Arreola MP, Figuera-Villanueva LE, Ramos-Silva A, Salas-González E, Puebla-Pérez AM, Peralta-Leal V, García-Ortiz JE, Dávalos-Rodríguez IP, Zúñiga-González GM. The association between the 844ins68 polymorphism in the CBS gene and breast cancer. Arch Med Sci 2014;10:1214-24. [PMID: 25624861 DOI: 10.5114/aoms.2014.47830] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hong SW, Lee HJ, Han K, Moon JM, Park S, Soh H, Kang EA, Chun J, Im JP, Kim JS. Risk of gastrointestinal cancer in patients with an elevated level of gamma-glutamyltransferase: A nationwide population-based study. PLoS One 2021;16:e0245052. [PMID: 33544706 DOI: 10.1371/journal.pone.0245052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Van Hemelrijck M, Eichholzer M, Faeh D, Rohrmann S. Ability of a biomarker-based score to predict death from circulatory disease and cancer in NHANES III. BMC Public Health 2012;12:895. [PMID: 23092358 DOI: 10.1186/1471-2458-12-895] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
14 Park WY, Koh ES, Kim SH, Kim YO, Jin DC, Song HC, Choi EJ, Kim YL, Kim YS, Kang SW, Kim NH, Yang CW, Kim YK. Serum Gamma-Glutamyltransferase Levels Predict Clinical Outcomes in Hemodialysis Patients. PLoS One 2015;10:e0138159. [PMID: 26376075 DOI: 10.1371/journal.pone.0138159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Grimm C, Hofstetter G, Aust S, Mutz-Dehbalaie I, Bruch M, Heinze G, Rahhal-Schupp J, Reinthaller A, Concin N, Polterauer S. Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer. Br J Cancer 2013;109:610-4. [PMID: 23921280 DOI: 10.1038/bjc.2013.323] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
16 Choi YJ, Lee DH, Han KD, Yoon H, Shin CM, Park YS, Kim N. Elevated serum gamma-glutamyltransferase is associated with an increased risk of oesophageal carcinoma in a cohort of 8,388,256 Korean subjects. PLoS One. 2017;12:e0177053. [PMID: 28475598 DOI: 10.1371/journal.pone.0177053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
17 Huang R, Yang CC, Liu Y, Xia J, Su R, Xiong YL, Wang GY, Sun ZH, Yan XM, Lu S, Wu C. Association of serum gamma-glutamyl transferase with treatment outcome in chronic hepatitis B patients. World J Gastroenterol 2015; 21(34): 9957-9965 [PMID: 26379400 DOI: 10.3748/wjg.v21.i34.9957] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
18 Dalpiaz O, Pichler M, Mrsic E, Reitz D, Krieger D, Venturino L, Bezan A, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC. Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma. J Clin Pathol 2015;68:547-51. [PMID: 25862811 DOI: 10.1136/jclinpath-2014-202683] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
19 Seebacher V, Polterauer S, Grimm C, Rahhal J, Hofstetter G, Bauer EM, Husslein H, Leipold H, Marth C, Reinthaller A, Concin N. Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial. Br J Cancer 2012;106:1551-5. [PMID: 22315051 DOI: 10.1038/bjc.2012.16] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
20 Sun L, Yin W, Wu Z, Wang Y, Lu J. The Predictive Value of Pre-therapeutic Serum Gamma-glutamyl transferase in Efficacy and Adverse Reactions to Neoadjuvant Chemotherapy among Breast Cancer Patients. J Breast Cancer 2020;23:509-20. [PMID: 33154826 DOI: 10.4048/jbc.2020.23.e59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Schwameis R, Grimm C, Brodowicz T, Petru E, Hefler-Frischmuth K, Staudigl C, Reinthaller A, Heinze G, Polterauer S, Polterauer M. Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma. Sci Rep 2016;6:33757. [PMID: 27646551 DOI: 10.1038/srep33757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
22 Su S, Liu L, Sun C, Nie Y, Guo H, Hu Y, Guo S, Pang S. Preoperative Serum Gamma-Glutamyltransferase as a Prognostic Biomarker in Patients Undergoing Radical Cystectomy for Bladder Cancer. Front Oncol 2021;11:648904. [PMID: 34026623 DOI: 10.3389/fonc.2021.648904] [Reference Citation Analysis]
23 Santaolalla A, Garmo H, Grigoriadis A, Ghuman S, Hammar N, Jungner I, Walldius G, Lambe M, Holmberg L, Van Hemelrijck M. Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis. BMC Mol Cell Biol 2019;20:28. [PMID: 31337337 DOI: 10.1186/s12860-019-0210-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Yang S, He X, Liu Y, Ding X, Jiang H, Tan Y, Lu H. Prognostic Significance of Serum Uric Acid and Gamma-Glutamyltransferase in Patients with Advanced Gastric Cancer. Dis Markers 2019;2019:1415421. [PMID: 31885729 DOI: 10.1155/2019/1415421] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
25 Khalaf MY, Mohammed AA, Mosa AA, Arif SH, Mustafa JA. The correlation of antioxidant levels of breast cancer: A case controlled study. Medicine (Baltimore) 2021;100:e26878. [PMID: 34477121 DOI: 10.1097/MD.0000000000026878] [Reference Citation Analysis]
26 Orzechowska D, Klimowicz K, Stępień A, Mikuła T, Sapuła M, Wiercińska-Drapało A. Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C. Clin Exp Hepatol 2021;7:93-100. [PMID: 34027121 DOI: 10.5114/ceh.2021.104466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Walldius G, Malmström H, Jungner I, de Faire U, Lambe M, Van Hemelrijck M, Hammar N. Cohort Profile: The AMORIS cohort. International Journal of Epidemiology 2017;46:1103-1103i. [DOI: 10.1093/ije/dyw333] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
28 Xu L, Leng C, Chen L, Dong H, Chen Y, Chen X. Hypothyroidism is a predictive factor of superior antitumour efficacy of programmed death 1 inhibitors in hepatocellular carcinoma. Int J Cancer 2021. [PMID: 34536292 DOI: 10.1002/ijc.33813] [Reference Citation Analysis]
29 Battisti V, Bagatini MD, Maders LD, Chiesa J, Santos KF, Gonçalves JF, Abdalla FH, Battisti IE, Schetinger MR, Morsch VM. Cholinesterase activities and biochemical determinations in patients with prostate cancer: Influence of Gleason score, treatment and bone metastasis. Biomedicine & Pharmacotherapy 2012;66:249-55. [DOI: 10.1016/j.biopha.2011.11.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
30 Preyer O, Johansen D, Holly J, Stocks T, Pompella A, Nagel G, Concin H, Ulmer H, Concin N. γ-Glutamyltransferase and Breast Cancer Risk Beyond Alcohol Consumption and Other Life Style Factors - A Pooled Cohort Analysis. PLoS One 2016;11:e0149122. [PMID: 26863311 DOI: 10.1371/journal.pone.0149122] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
31 Wang Y, Jadhav RR, Liu J, Wilson D, Chen Y, Thompson IM, Troyer DA, Hernandez J, Shi H, Leach RJ, Huang TH, Jin VX. Roles of Distal and Genic Methylation in the Development of Prostate Tumorigenesis Revealed by Genome-wide DNA Methylation Analysis. Sci Rep 2016;6:22051. [PMID: 26924343 DOI: 10.1038/srep22051] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
32 Luo M, Sun W, Wu C, Zhang L, Liu D, Li W, Mei Q, Hu G. High pretreatment serum gamma-glutamyl transpeptidase predicts an inferior outcome in nasopharyngeal carcinoma. Oncotarget 2017;8:67651-62. [PMID: 28978060 DOI: 10.18632/oncotarget.18798] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
33 Kunutsor SK, Laukkanen JA. Gamma-glutamyltransferase and risk of prostate cancer: Findings from the KIHD prospective cohort study. Int J Cancer 2017;140:818-24. [PMID: 27861848 DOI: 10.1002/ijc.30511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
34 Lu LH, Wei-Wei, Kan A, Jie-Mei, Ling YH, Li SH, Guo RP. Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma. Dis Markers 2020;2020:4269460. [PMID: 32695241 DOI: 10.1155/2020/4269460] [Reference Citation Analysis]
35 Bosco C, Garmo H, Hammar N, Walldius G, Jungner I, Malmström H, Holmberg L, Van Hemelrijck M. Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort. BMC Cancer 2018;18:205. [PMID: 29463235 DOI: 10.1186/s12885-018-4111-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Stepien M, Fedirko V, Duarte-Salles T, Ferrari P, Freisling H, Trepo E, Trichopoulou A, Bamia C, Weiderpass E, Olsen A, Tjønneland A, Overvad K, Boutron-Ruault MC, Fagherazzi G, Racine A, Kühn T, Kaaks R, Aleksandrova K, Boeing H, Lagiou P, Benetou V, Trichopoulos D, Palli D, Grioni S, Tumino R, Naccarati A, Panico S, Bueno-de-Mesquita HB, Peeters PH, Lund E, Quirós JR, Nápoles OC, Sánchez MJ, Dorronsoro M, Huerta JM, Ardanaz E, Ohlsson B, Sjöberg K, Werner M, Nystrom H, Khaw KT, Key TJ, Gunter M, Cross A, Riboli E, Romieu I, Jenab M. Prospective association of liver function biomarkers with development of hepatobiliary cancers. Cancer Epidemiol 2016;40:179-87. [PMID: 26773278 DOI: 10.1016/j.canep.2016.01.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
37 Carlsson AC, Wändell PE, Hedlund E, Walldius G, Nordqvist T, Jungner I, Hammar N. Country of birth-specific and gender differences in prevalence of diabetes in Sweden. Diabetes Res Clin Pract 2013;100:404-8. [PMID: 23618551 DOI: 10.1016/j.diabres.2013.03.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
38 Kunutsor SK, Apekey TA, Van Hemelrijck M, Calori G, Perseghin G. Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: systematic review and meta-analysis. Int J Cancer. 2015;136:1162-1170. [PMID: 25043373 DOI: 10.1002/ijc.29084] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
39 Huang CF, Yeh ML, Tsai PC, Hsieh MH, Yang HL, Hsieh MY, Yang JF, Lin ZY, Chen SC, Wang LY, Dai CY, Huang JF, Chuang WL, Yu ML. Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication. J Hepatol. 2014;61:67-74. [PMID: 24613362 DOI: 10.1016/j.jhep.2014.02.022] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 10.8] [Reference Citation Analysis]
40 Huang J, Mondul AM, Weinstein SJ, Derkach A, Moore SC, Sampson JN, Albanes D. Prospective serum metabolomic profiling of lethal prostate cancer. Int J Cancer 2019;145:3231-43. [PMID: 30779128 DOI: 10.1002/ijc.32218] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
41 Yang F, Zhang S, Yang H, Luo K, Wen J, Hu Y, Hu R, Huang Q, Chen J, Fu J. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma. Dis Esophagus 2015;28:496-504. [PMID: 24766310 DOI: 10.1111/dote.12227] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
42 Stolzenberg-Solomon R, Derkach A, Moore S, Weinstein SJ, Albanes D, Sampson J. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study. Gut 2020;69:2008-15. [PMID: 32060129 DOI: 10.1136/gutjnl-2019-319811] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Essén A, Santaolalla A, Garmo H, Hammar N, Walldius G, Jungner I, Malmström H, Holmberg L, Van Hemelrijck M. Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort. Cancer Causes Control 2019;30:603-15. [PMID: 31020446 DOI: 10.1007/s10552-019-01170-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
44 Kengne AP, Czernichow S, Stamatakis E, Hamer M, Batty GD. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: Pooling of three British Health Surveys. Journal of Hepatology 2012;57:1083-9. [DOI: 10.1016/j.jhep.2012.06.034] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
45 Staudigl C, Concin N, Grimm C, Pfeiler G, Nehoda R, Singer CF, Polterauer S. Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer. PLoS One 2015;10:e0125317. [PMID: 25915044 DOI: 10.1371/journal.pone.0125317] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
46 Hong TC, Yang HC, Chen CL, Kao JH, Liu CJ, Chen MJ, Wang HY, Kuo YC, Yu LY, Hu KC. Relationship between serum gamma-glutamyl transferase level and colorectal adenoma. PLoS One 2020;15:e0240445. [PMID: 33048943 DOI: 10.1371/journal.pone.0240445] [Reference Citation Analysis]
47 Yang W, Kim CK, Kim DY, Jeong H, Lee S. Gamma-glutamyl transferase predicts future stroke: A Korean nationwide study: GGT Predicts Future Stroke. Ann Neurol 2018;83:375-86. [DOI: 10.1002/ana.25158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
48 Shackshaft L, Van Hemelrijck M, Garmo H, Malmström H, Lambe M, Hammar N, Walldius G, Jungner I, Wulaningsih W. Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort. Breast Cancer Res 2017;19:22. [PMID: 28264697 DOI: 10.1186/s13058-017-0816-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
49 Wen YF, Yang XZ, Zeng LS, Peng HH, Huang WJ, Cai LM, Zhou TC, Lin XD. Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma. PLoS One 2017;12:e0172345. [PMID: 28241022 DOI: 10.1371/journal.pone.0172345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
50 Takemura K, Board PG, Koga F. A Systematic Review of Serum γ-Glutamyltransferase as a Prognostic Biomarker in Patients with Genitourinary Cancer. Antioxidants (Basel) 2021;10:549. [PMID: 33916150 DOI: 10.3390/antiox10040549] [Reference Citation Analysis]
51 Park SK, Zhao Z, Mukherjee B. Construction of environmental risk score beyond standard linear models using machine learning methods: application to metal mixtures, oxidative stress and cardiovascular disease in NHANES. Environ Health 2017;16:102. [PMID: 28950902 DOI: 10.1186/s12940-017-0310-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
52 Lee CH, Han K, Kim DH, Kwak MS. Repeatedly elevated γ-glutamyltransferase levels are associated with an increased incidence of digestive cancers: A population-based cohort study. World J Gastroenterol 2021; 27(2): 176-188 [PMID: 33510558 DOI: 10.3748/wjg.v27.i2.176] [Reference Citation Analysis]
53 Fisher L, Srikusalanukul W, Fisher A, Smith P. Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes. Int J Med Sci 2015;12:100-15. [PMID: 25589886 DOI: 10.7150/ijms.10696] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
54 Everhart JE, Wright EC. Association of γ-glutamyl transferase (GGT) activity with treatment and clinical outcomes in chronic hepatitis C (HCV). Hepatology. 2013;57:1725-1733. [PMID: 23258530 DOI: 10.1002/hep.26203] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
55 Coppell KJ, Miller JC, Gray AR, Schultz M, Mann JI, Parnell WR. Obesity and the extent of liver damage among adult New Zealanders: findings from a national survey. Obes Sci Pract 2015;1:67-77. [PMID: 27774250 DOI: 10.1002/osp4.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
56 Hino R, Inoshita N, Yoshimoto T, Ogawa M, Miura D, Watanabe R, Watanabe K, Kamiya M, Urano Y. Rapid detection of papillary thyroid carcinoma by fluorescence imaging using a γ-glutamyltranspeptidase-specific probe: a pilot study. Thyroid Res 2018;11:16. [PMID: 30479665 DOI: 10.1186/s13044-018-0060-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
57 Kawakami K, Fujita Y, Matsuda Y, Arai T, Horie K, Kameyama K, Kato T, Masunaga K, Kasuya Y, Tanaka M, Mizutani K, Deguchi T, Ito M. Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer. BMC Cancer 2017;17:316. [PMID: 28476099 DOI: 10.1186/s12885-017-3301-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
58 Guo J, Liu S, Gao S, Kou F, Zhang X, Liu P, Yang R, Zhu X. γ-Glutamyltranspeptidase as a Prognostic Biomarker in Advanced Hepatocellular Carcinoma Treated with Transarterial Chemoembolization. J Vasc Interv Radiol 2021;32:419-428.e2. [PMID: 33067120 DOI: 10.1016/j.jvir.2020.07.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Bosco C, Wulaningsih W, Melvin J, Santaolalla A, De Piano M, Arthur R, Van Hemelrijck M. Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS study. Ecancermedicalscience 2015;9:555. [PMID: 26284119 DOI: 10.3332/ecancer.2015.555] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
60 Brand H, Diergaarde B, O'Connell MR, Whitcomb DC, Brand RE. Variation in the γ-glutamyltransferase 1 gene and risk of chronic pancreatitis. Pancreas 2013;42:836-40. [PMID: 23462328 DOI: 10.1097/MPA.0b013e318279f720] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
61 Akaydın SY, Salihoğlu EM, Güngör DG, Karanlık H, Demokan S. Correlation Between Gamma-Glutamyl Transferase Activity and Glutathione Levels in Molecular Subgroups of Breast Cancer. Eur J Breast Health 2020;16:72-6. [PMID: 31912018 DOI: 10.5152/ejbh.2019.5147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
62 Bozkaya Y, Yazıcı O. Prognostic significance of gamma-glutamyl transferase in patients with metastatic non-small cell lung cancer. Expert Rev Mol Diagn 2019;19:267-72. [PMID: 30722710 DOI: 10.1080/14737159.2019.1579644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]